Janindra Warusavitarne

ORCID: 0000-0002-7950-2833
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Diverticular Disease and Complications
  • Colorectal Cancer Surgical Treatments
  • Anorectal Disease Treatments and Outcomes
  • Microscopic Colitis
  • Gastric Cancer Management and Outcomes
  • Pelvic floor disorders treatments
  • Colorectal and Anal Carcinomas
  • Colorectal Cancer Screening and Detection
  • Abdominal Surgery and Complications
  • Hernia repair and management
  • Genetic factors in colorectal cancer
  • Cardiac, Anesthesia and Surgical Outcomes
  • Stoma care and complications
  • Autoimmune and Inflammatory Disorders
  • Pelvic and Acetabular Injuries
  • Gastrointestinal Tumor Research and Treatment
  • Diagnosis and treatment of tuberculosis
  • Gastrointestinal disorders and treatments
  • Colorectal Cancer Treatments and Studies
  • Appendicitis Diagnosis and Management
  • Clinical Nutrition and Gastroenterology
  • Esophageal and GI Pathology
  • Metastasis and carcinoma case studies
  • Enhanced Recovery After Surgery

St Mark's Hospital
2016-2025

London North West Healthcare NHS Trust
2013-2024

Western Eye Hospital
2023

Imperial College London
2014-2023

Northwick Park Hospital
2013-2023

Mater Misericordiae University Hospital
2022

St. Mark's Hospital
2015-2021

Marks and Spencer (United Kingdom)
2015-2020

University of Rochester Medical Center
2020

St Mary's Hospital
2017-2019

This article is the second in a series of two publications relating to European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on management disease. The first covers medical management; present addresses surgical management, including preoperative aspects drug before surgery. It also provides technical advice for variety common clinical situations. Both articles together represent recommendations ECCO disease an update previous guidelines.

10.1093/ecco-jcc/jjz187 article EN Journal of Crohn s and Colitis 2019-11-15

This study aims to report short-term clinical and oncological outcomes from the international transanal Total Mesorectal Excision (taTME) registry for benign malignant rectal pathology.TaTME is latest minimally invasive technique pioneered facilitate difficult pelvic dissections. Outcomes have been published small cohorts, but larger series can further assess safety efficacy of taTME in wider surgical population.Data were analyzed 66 registered units 23 countries. The primary endpoint was...

10.1097/sla.0000000000001948 article EN Annals of Surgery 2016-10-05

The goal of this consensus initiated by the European Crohn's and Colitis Organisation (ECCO) was to establish guidelines for surgical treatment ulcerative colitis. strategy reach involved several steps follows standard operating procedures ECCO. An open call chairs participants made (see acknowledgements www.ecco-ibd). Participants were selected Guidelines' Committee ECCO (GuiCom) on basis their publication record a personal statement. Four working groups (WGs) formed: WG 1 preoperative...

10.1016/j.crohns.2014.08.012 article EN Journal of Crohn s and Colitis 2014-10-09

Objective: To determine the incidence of anastomotic-related morbidity following Transanal Total Mesorectal Excision (TaTME) and identify independent risk factors for failure. Background: Anastomotic leak its sequelae are dreaded complications gastrointestinal surgery. TaTME is a recent technique rectal resection, which includes novel anastomotic techniques. Methods: Prospective study consecutive reconstructed cases recorded over 30 months in 107 surgical centers across 29 countries. Primary...

10.1097/sla.0000000000002653 article EN Annals of Surgery 2018-01-04

Objectives: This study provides an overview of the largest and longest-running colonoscopic surveillance program for colorectal cancer (CRC) in patients with long-standing ulcerative colitis (UC). Methods: Data were obtained from medical records, endoscopy, histology reports. Primary end points defined as death, colectomy, withdrawal surveillance, or censor date (1 January 2013). Results: A total 1,375 UC followed up 15,234 patient-years (median, 11 years per patient). CRC was detected 72...

10.1038/ajg.2015.65 article EN The American Journal of Gastroenterology 2015-03-31

Abstract This article is the second in a series of two publications on European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus management disease. The first covers medical management; present addresses surgical management, including preoperative aspects drug before surgery. It also provides technical advice for variety common clinical situations. Both articles together represent recommendations ECCO disease an update prior Guidelines.

10.1093/ecco-jcc/jjae089 article EN other-oa Journal of Crohn s and Colitis 2024-06-14

Objective Ulcerative colitis (UC) is a dynamic disease with its severity continuously changing over time. We hypothesised that the risk of colorectal neoplasia (CRN) in UC closely follows an actuarial accumulative inflammatory burden, which inadequately represented by current stratification strategies. Design This was retrospective single-centre study. Patients extensive who were under colonoscopic surveillance between 2003 and 2012 studied. Each episode scored for microscopic inflammation...

10.1136/gutjnl-2017-314190 article EN cc-by Gut 2017-11-17

OBJECTIVES: The aim of this study was to identify risk factors associated with development high-grade dysplasia (HGD) or colorectal cancer (CRC) in ulcerative colitis (UC) patients diagnosed low-grade (LGD). METHODS: Patients histologically confirmed extensive UC, who were LGD between 1993 and 2012 at St Mark's Hospital, identified followed up 1 July 2013. Demographic, endoscopic, histological data collected correlated the HGD CRC. RESULTS: A total 172 for a median 48 months from date...

10.1038/ajg.2015.248 article EN The American Journal of Gastroenterology 2015-09-29

Intra-abdominal septic complications [IASC] following ileocolonic resection for Crohn's disease are common. Determining risk factors these can aid pre-operative and peri-operative strategies to reduced morbidity. This study aims determine the incidence predictors of intra-abdominal disease. A single-centre, retrospective was conducted. The clinical case notes patients with histopathologically proven disease, who underwent an as a one-stage or two-stage procedure, were reviewed. primary...

10.1093/ecco-jcc/jjv051 article EN Journal of Crohn s and Colitis 2015-03-21

Abstract Aim Laparoscopic surgery is well established for colon cancer, with defined benefits. Use of laparoscopy the performance restorative proctocolectomy ( RPC ) ileoanal anastomosis more controversial. Technical aspects include difficult dissection distal rectum and a potentially increased risk anastomotic leakage through multiple firings stapler. In an attempt to overcome these difficulties we have used technique transanal rectal excision perform proctectomy. This paper describes...

10.1111/codi.13359 article EN Colorectal Disease 2016-04-26

Abstract Aim There is a requirement of an expansive and up to date review surgical management inflammatory bowel disease ( IBD ) that can dovetail with the medical guidelines produced by British Society Gastroenterology. Methods Surgeons who are members ACPGBI recognised interest in were invited contribute various sections guidelines. They directed produce procedure based document using literature searches systematic, comprehensible, transparent reproducible. Levels evidence graded. An...

10.1111/codi.14448 article EN cc-by Colorectal Disease 2018-12-01
Coming Soon ...